Us Bancorp \De\ Ionis Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 4,220 shares of IONS stock, worth $132,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,220

Previous 5,730 26.35%

Holding current value

$132,845

Previous $229,000 35.81%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$33.73 - $40.36 $50,932 - $60,943	-1,510 Reduced 26.35%	4,220 $147,000
Q3 2024 Oct 28, 2024	SELL	$40.06 - $51.86 $213,119 - $275,895	-5,320 Reduced 48.14%	5,730 $229,000
Q2 2024 Aug 06, 2024	SELL	$36.45 - $47.7 $31,966 - $41,832	-877 Reduced 7.35%	11,050 $526,000
Q1 2024 May 07, 2024	SELL	$42.03 - $53.55 $336 - $428	-8 Reduced 0.07%	11,927 $517,000
Q4 2023 Feb 09, 2024	SELL	$43.39 - $51.63 $61,743 - $73,469	-1,423 Reduced 10.65%	11,935 $603,000
Q3 2023 Nov 03, 2023	SELL	$38.5 - $47.13 $25,487 - $31,200	-662 Reduced 4.72%	13,358 $605,000
Q2 2023 Aug 09, 2023	SELL	$34.73 - $43.33 $73,002 - $91,079	-2,102 Reduced 13.04%	14,020 $575,000
Q1 2023 May 09, 2023	BUY	$33.58 - $41.2 $43,721 - $53,642	1,302 Added 8.79%	16,122 $576,000
Q4 2022 Feb 13, 2023	SELL	$37.12 - $46.52 $51,151 - $64,104	-1,378 Reduced 8.51%	14,820 $559,000
Q3 2022 Oct 27, 2022	SELL	$36.54 - $48.66 $41,107 - $54,742	-1,125 Reduced 6.49%	16,198 $717,000
Q2 2022 Aug 01, 2022	SELL	$31.71 - $43.0 $131,120 - $177,805	-4,135 Reduced 19.27%	17,323 $641,000
Q1 2022 May 11, 2022	BUY	$29.88 - $37.04 $70,008 - $86,784	2,343 Added 12.26%	21,458 $795,000
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $69,966 - $95,893	2,732 Added 16.68%	19,115 $582,000
Q3 2021 Nov 10, 2021	BUY	$33.54 - $40.55 $79,657 - $96,306	2,375 Added 16.95%	16,383 $550,000
Q2 2021 Aug 05, 2021	BUY	$34.54 - $47.25 $14,575 - $19,939	422 Added 3.11%	14,008 $558,000
Q1 2021 Apr 28, 2021	BUY	$42.51 - $63.78 $470,500 - $705,917	11,068 Added 439.56%	13,586 $610,000
Q4 2020 Feb 04, 2021	BUY	$45.3 - $60.27 $40,905 - $54,423	903 Added 55.91%	2,518 $142,000
Q3 2020 Nov 10, 2020	BUY	$47.45 - $62.95 $12,004 - $15,926	253 Added 18.58%	1,615 $76,000
Q2 2020 Aug 07, 2020	SELL	$46.85 - $61.05 $42,961 - $55,982	-917 Reduced 40.24%	1,362 $80,000
Q1 2020 May 13, 2020	BUY	$41.6 - $63.4 $12,230 - $18,639	294 Added 14.81%	2,279 $107,000
Q4 2019 Feb 04, 2020	SELL	$53.85 - $65.27 $23,047 - $27,935	-428 Reduced 17.74%	1,985 $120,000
Q3 2019 Nov 08, 2019	BUY	$59.06 - $72.15 $24,509 - $29,942	415 Added 20.77%	2,413 $145,000
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $1,614 - $2,239	-26 Reduced 1.28%	1,998 $129,000
Q1 2019 May 08, 2019	BUY	$52.92 - $81.17 $18,257 - $28,003	345 Added 20.55%	2,024 $164,000
Q4 2018 Feb 13, 2019	SELL	$43.37 - $59.54 $83,964 - $115,269	-1,936 Reduced 53.55%	1,679 $91,000
Q3 2018 Nov 01, 2018	SELL	$42.88 - $53.7 $60,289 - $75,502	-1,406 Reduced 28.0%	3,615 $186,000
Q2 2018 Aug 08, 2018	SELL	$40.53 - $50.7 $32,180 - $40,255	-794 Reduced 13.65%	5,021 $210,000
Q1 2018 May 08, 2018	BUY	$44.08 - $55.05 $15,648 - $19,542	355 Added 6.5%	5,815 $257,000
Q4 2017 Feb 02, 2018	BUY	$50.3 - $64.39 $15,492 - $19,832	308 Added 5.98%	5,460 $274,000
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $234,725 - $306,904	5,152	5,152 $261,000

Others Institutions Holding IONS

# of Institutions

414

Shares Held

136M

Call Options Held

861K

Put Options Held

617K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.47B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account